Pyzchiva Receives FDA Approval as Third Ustekinumab BiosimilarJuly 2, 2024Rare DiseasesMusculoskeletal DisordersDermatologyGastroenterology
The Appendix: Is It ’Useless,’ or a Safe House and Immune Training Ground?June 10, 2024GastroenterologyInfectious Diseases
FDA Grants New Pediatric Arthritis Indications for UpadacitinibJune 7, 2024Rare DiseasesMusculoskeletal DisordersGastroenterologyDermatology
Gene Tests Could Predict if a Drug Will Work for a PatientMay 31, 2024OncologyCardiologyMental HealthGastroenterologyInfectious Diseases
Specialists Are ‘Underwater’ With Some Insurance-Preferred BiosimilarsMay 16, 2024Business of MedicineGastroenterologyDermatology
Video Games Marketing Food Impacts Teens’ EatingMay 13, 2024Adolescent MedicineGastroenterologyObesity
The Long, Controversial Search for a ‘Cancer Microbiome’May 6, 2024GastroenterologyMixed TopicsOncology
Infant Microbiome Development Minimally Affected by Diet, but Metabolite Profiles DifferApril 15, 2024GastroenterologyNeonatal Medicine
Few Childhood Cancer Survivors Get Recommended ScreeningsMarch 25, 2024GastroenterologyOncologyCardiologyMixed TopicsBusiness of Medicine
FDA Approves 10th Humira Biosimilar, With InterchangeabilityFebruary 27, 2024GastroenterologyRare DiseasesMusculoskeletal DisordersDermatology
What Skin Manifestations Are Associated With Pediatric IBD?February 21, 2024Infectious DiseasesDermatologyGastroenterologyAdolescent Medicine
